首页> 美国卫生研究院文献>American Journal of Clinical and Experimental Immunology >Tumor-infiltrating regulatory T cells: origins and features
【2h】

Tumor-infiltrating regulatory T cells: origins and features

机译:肿瘤浸润调节性T细胞的起源和特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor cells evolve multiple sophisticated mechanisms to escape immune surveillance, one of which is to establish tolerogenic microenvironment by recruiting certain immune suppressive cells such as regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs). Tregs are subpopulation of CD4+ T cells, which specialize in suppressing immune responses and preventing autoimmune damage to collateral tissue. Emerging evidence suggests that Treg cell number increases in various types of cancer, which correlates with tumor grade and poor patient prognosis. This review will focus on discussion of the origins and features of tumor-infiltrating Treg cells. Ultimately, these features may provide insight into potential therapeutic intervention by targeting Treg cells to invigorate immune response against tumor.
机译:肿瘤细胞进化出多种复杂的机制来逃避免疫监视,其中一种机制是通过募集某些免疫抑制细胞(例如调节性T细胞(Tregs)和髓样来源的抑制细胞(MDSCs))来建立致耐受性微环境。 Tregs是CD4 + T细胞的亚群,专门用于抑制免疫反应和预防对旁支组织的自身免疫损伤。新兴证据表明,在各种类型的癌症中,Treg细胞数量增加,这与肿瘤等级和患者预后不良相关。本文将重点讨论肿瘤浸润Treg细胞的起源和特征。最终,这些特征可通过靶向Treg细胞以增强针对肿瘤的免疫反应来提供对潜在治疗干预的见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号